Showing results (281-290 of 334) with videos related to
Sort By:
Pageof 34
Influenza and Other Respiratory Viruses|April 8, 2014
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccinesGerrit A van Essen, Jiri Beran, Jeanne-Marie Devaster, et al.Influenza and Other Respiratory Viruses|February 6, 2020
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela M C Rose, Esther Kissling, Alin Gherasim, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical TrialPaul Loubet, Sébastien Czernichow, Caroline Giboin, et al.The Journal of Infectious Diseases|February 1, 2014
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessAnn R Falsey, Janet E McElhaney, Jiri Beran, et al.Journal of Gynecology Obstetrics and Human Reproduction|December 14, 2020
SARS-COV-2 IgG antibody response in pregnant women at deliveryVassilis Tsatsaris, Alice-Andrée Mariaggi, Odile Launay, et al.Msphere|April 16, 2025
Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to ShigellaArlo Z Randall, Valentino Conti, Usman Nakakana, et al.Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.Advances in Therapy|December 16, 2024
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised IndividualsChristoph D Spinner, Samira Bell, Hermann Einsele, et al.Human Vaccines & Immunotherapeutics|October 4, 2016
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysisGuillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, et al.Vaccine|November 11, 2025
Rotasiil vaccine effectiveness against rotavirus-associated hospitalizations in the Democratic Republic of the Congo: comparison of multivariate logistic regression and inverse probability treatment weighting methods in a test-negative designChristophe Luhata Lungayo, Eleanor Burnett, Audry Mulumba, et al.Pageof 34